Interní Med. 2009; 11(1): 48-50

What is new in andrological endocrinology

prof. MUDr. RNDr. Luboslav Stárka DrSc
Endokrinologický ústav, Praha

The aim of the paper is to highlight some current issues and recent findings concerning andrological endocrinology.

Keywords: Key words: testosterone, treatment, secular trends, prostate, thyropathy, male contraception.

Published: March 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Stárka L. What is new in andrological endocrinology. Interní Med. 2009;11(1):48-50.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hu LQ. [Future development of andrology in China] Zhonghua Nan Ke Xue. 2005; 11 (1): 3-6. Go to PubMed...
    2. AA. [The role of andrology as a field of reproductive medicine in the solution of demographic problems in Russia] Vestn Ross Akad Med Nauk 2007; (11): 50-52.
    3. Bhasin S, Cunnigham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995-2010. Go to original source... Go to PubMed...
    4. The Practice Committee of the American Society for Reproductive Medicine. Treatment of androgen deficiency in the aging male. Fertil Steril 2004; 82 (Suppl 1): S46-50. Go to original source... Go to PubMed...
    5. Ritzén EM, Bergh A, Bjerknes R, Christiansen P, Cortes D, Haugen SE, Jörgensen N, Kollin C, Lindahl S, Läckgren G, Main KM, Nordenskjöld A, Rajpert-De Meyts E, Söder O, Taskinen S, Thorsson A, Thorup J, Toppari J, Virtanen H. Nordic consensus on treatment of undescended testes. Acta Paediatr 2007; 96 (5): 638-643. Go to original source... Go to PubMed...
    6. Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology. Revised guidelines for human embryology and andrology laboratories. Fertil Steril 2006; 86 (5 Suppl): S57-72. Go to original source... Go to PubMed...
    7. Simoni M, Bakker E, Krausz C. EAA/EMQN best practice guidelines for molecular diagnosis of y-chromosomal microdeletions. State of the art 2004. Int J Androl 2004; 27 (4): 240-249. Go to original source... Go to PubMed...
    8. Handelsman D. Update in andrology. J Clin Endocrinol Metab 2007; 92 (12): 4505-4511. Go to original source... Go to PubMed...
    9. Yavuz BB, Ozkayar N, Halil M, Cankurtaran M, Ulger Z, Tezcan E, Gurlek A, Ariogul S. Free testosterone levels and implications on clinical outcomes in elderly men. Aging Clin Exp Res 2008; 20: 201-206. Go to original source... Go to PubMed...
    10. Laughlin GA, Barrett-Connor E, Bergstrom J. Low testosterone and mortality in older men. J Clin Endocrinol Metab 2008; 93: 68-75. Go to original source... Go to PubMed...
    11. Allan C, Strauss BJ, Burger HG, Forbes EA, McLachlan RI. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab 2008; 93 (1): 139-146. Go to original source... Go to PubMed...
    12. Miner M, Canty DJ, Shabsigh R.Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices. Postgrad Med 2008; 120 (3): 130-153. Go to original source... Go to PubMed...
    13. Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, Macairan ML, Nelson PS. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. J Amer Med Assoc 2006; 296 (19): 2351-2361. Go to original source... Go to PubMed...
    14. Rhoden EL, Riedner CE, Morgentaler A. The ratio of serum testosterone-to-prostate specific antigen predicts prostate cancer in hypogonadal men. J Urol 2008; 179 (5): 1741-1744. Go to original source... Go to PubMed...
    15. Svatek RS, Shulman MJ, Benaim EA, Rogers TE, Marqulis V. Change in prostate specific antigen following androgen stimulation is an independent predictor of prostate cancer diagnosis. J Urol 2008; 179: 2192-2195. Go to original source... Go to PubMed...
    16. Uemura M Tamura K, Chung S, Honma S, Okuyama A, Nakamura Y, Nakagawa H. Novel 5alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Cancer Sci 2008; 99 (1): 81-86. Go to original source...
    17. Tindall DJ, Rittmaster RS. Rationale for inhibiting 5alphareductase isoenzymes in the prevention and treatment of prostate cancer. J Urol 2008; 179: 1235-1242. Go to original source... Go to PubMed...
    18. Barnard RJ. Prostate cancer prevention by nutritional means to alleviate metabolic syndrome. Am J Clin Nutr 2007; 86 (3): 889-893. Go to original source... Go to PubMed...
    19. Stacewicz-Sapuntzakis M, Borthakur G, Burns JL, Bowen PE. Correlations of dietary patterns with prostate health. Mol Nutr Food Res 2008; 52 (1): 114-130. Go to original source... Go to PubMed...
    20. Khan N, Afaq F, Mukhtar H. Cancer chemoprevention through dietary antioxidants: Progress and promise. Antioxid Redox Signal 2008; 10 (3): 475-510. Go to original source... Go to PubMed...
    21. Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, Albanes D, Andriole GL, Urban DA, Peters U. PLCO Trial. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006; 98 (4): 245-254. Go to original source... Go to PubMed...
    22. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, Thompson IM. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: Results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2008; 167 (8): 925-934. Go to original source... Go to PubMed...
    23. Harada N, Murata Y, Yamaji R, Miura T, Inui H, Nakano Y. Resveratrol down-regulates the androgen receptor at the post-translational level in prostate cancer cells. J Nutr Sci Vitaminol (Tokyo) 2008; 53 (6): 556-560. Go to original source... Go to PubMed...
    24. Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 2007; 12: 4839-4854. Go to original source... Go to PubMed...
    25. Wigle DT, Turner MC, Gomes J, Parent ME. Role of hormonal and other factors in human prostate cancer. J Toxicol Environ Health B Crit Rev 2008; 11: 242-259. Go to original source... Go to PubMed...
    26. Hammes A, Andreassen TK, Spoelgen R et al. Role of endocytosis in cellular uptake of sex steroids. Cell 2005; 122 (5): 751-762. Go to original source... Go to PubMed...
    27. Kozyraki R, Goffolt F. Multiligand endocytosis and congenital defects: roles of cubilin, megalin and amnionless. Curr Pharm Des 2007; 13 (29): 3038-3046. Go to original source... Go to PubMed...
    28. Bojensen A, Juul S, Birkebaek NH, Gravholt CH. Morbidity in Klinefelter syndrome; a Danish register study based on hospital discharge diagnoses. Clin Endocrinol Metab 2006; 91: 1254-1260. Go to original source... Go to PubMed...
    29. Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA. Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab 2005; 88: 6516-6522. Go to original source... Go to PubMed...
    30. Handelsman DJ, Liu PY. Klinefelters syndrome: a microcosmos of male reproductive health. J Clin Endocrinol Metab 2006; 91: 1220-1222. Go to original source... Go to PubMed...
    31. Lafranco F, Kamischke A, Zitzmann M, Nieschalg E. Klinefelters syndrome. Lancet 2004; 364: 273-283. Go to original source... Go to PubMed...
    32. Schiff JD, Palermo GD, Veeck LL, Goldstein M, Rosenwaks Z, Schlegel PN. Success of testicular sperm injection and intracyrtoplasmic sperm injection in men with Klinefelter syndrome. J Clin Endocrinol Metab 2005; 90: 6263-6267. Go to original source... Go to PubMed...
    33. Andersson AM, J?rgensen N, Main KM, Toppari J, RajpertDe Meyts E, Leffers H, Juul A, Jensen TK, Skakkebaek NE. Adverse trends in male reproductive health: we may have reached a crucial, tipping point'. Int J Androl 2008; 31 (2): 74-80. Go to original source... Go to PubMed...
    34. Skakkebaek NE, J?rgensen N, Main KM, Rajpert-De Meyts E, Leffers H, Andersson AM, Juul A, Carlsen E, Mortensen GK, Jensen TK, Toppari J. Is human fecundity declining? Int J Androl 2006; 29 (1): 2-11. Go to original source... Go to PubMed...
    35. Travison TG, Araujo AB, O'Donnell AB, Kupelian V, Mc-Kinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 2007; 92 (1): 196-202. Go to original source... Go to PubMed...
    36. Andersson AM, Jensen TK, Juul A, Petersen JH, J?rgensen T, Skakkebaek NE. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab 2007; 92 (12): 4696-4705. Go to original source... Go to PubMed...
    37. Liu PY, Swerdloff RS, Christenson PD, Handelsman DJ, Wang C. Hormonal Male Contraception Summit Group. Rate, extent and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis. Lancet 2006; 367: 1412-1420. Go to original source... Go to PubMed...
    38. Amory JK. Contraceptive developments for men. Drugs Today (Barc) 2007; 43 (3): 179-192. Go to original source... Go to PubMed...
    39. Heráček J, Urban M, Sobotka V, Lukeš M, Bittner L, Novotný T, Otava Z, Mužská antikoncepce Urol Listy 2007; 5: 2-33.
    40. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 2005; 90 (12): 6472-6479. Go to original source... Go to PubMed...
    41. Meeker JD, Godfrey-Bailey L, Hauser R. Relationships between serum hormone levels and semen quality among men from an infertility clinic. J Androl 2007; 28 (3): 397-406. Go to original source... Go to PubMed...
    42. Veronelli A, Masu A, Ranieri R, Rognoni C, Laneri M, Pontiroli AE. Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients. Int J Impot Res 2006; 18 (1): 111-114. Go to original source... Go to PubMed...
    43. Balercia G, Boscaro M, Lombardo F, Carosa E, Lenzi A, Jannini EA. Sexual symptoms in endocrine diseases: psychosomatic perspectives. Psychother Psychosom 2007; 76 (3): 134-140. Go to original source... Go to PubMed...
    44. Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract 2008; 62 (5): 791-798. Go to original source... Go to PubMed...
    45. Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet 2007; 369 (9561): 597-611. Go to original source... Go to PubMed...
    46. Berglund H, Lindström P, Dhejne-Helmy C, Savic I. Male-to-female transsexuals show sex-atypical hypothalamus activation when smelling odorous steroids. Cereb Cortex 2008; 18 (8): 1900-1908. Go to original source... Go to PubMed...
    47. Savic I, Berglund H, Lindström P. Brain response to putative pheromones in lesbian women. Proc Natl Acad Sci 2005; 102 (20): 7356-7361. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.